Scientists at UT Southwestern have identified the protein GADD45G as a master regulator of reactive gliosis, a damaging process in neurodegenerative diseases like Parkinson's and Alzheimer’s, offering a potential new therapeutic target.
CurePSP awarded CARES grants for multi-center projects aimed at improving care, access, and education for patients with PSP, CBD, and MSA.
In this Physical Therapy Products feature, Deborah Struiksma, PT, NCS, shares how consistent physical therapy with tried-and-true techniques helps patients with neurological damage restore compromised functions.
An international team of researchers led by Penn Medicine will investigate the link between TBI and dementias over the next five years.
The real-world study evaluated the impact of this approach to address neuromuscular walking challenges associated with foot drop.
The Mayo Clinic study suggests that the ability to balance on one leg, particularly the nondominant leg, is a more significant indicator of aging than strength or gait changes.
In people with primary progressive MS, a new study compared time before disability worsened between people receiving certain MS therapies and those not receiving treatment.
Black stroke patients arrive later to emergency departments, and EMS is less likely to notify hospitals of their condition ahead of time, a national study shows.
A large-scale study of military veterans suggests a possible link between hearing loss and increased risk of Parkinson’s disease.